Nilotinib is a classical c-Abl inhibitor that has been used in other neurodegenerative pathologies such as Parkinson’s disease (Pagan et al., 2019) and Alzheimer’s disease (Turner et al., 2020). The gene discussed is ABL1; the disease is Alzheimer disease.